ProCE Banner Activity

Emerging Biomarkers Poised to Change the Treatment Landscape in NSCLC

Slideset Download
Are you aware of the newest potential biomarkers in NSCLC? Download this slideset to gain expert insight on emerging biomarker-driven therapies in NSCLC.

Released: October 15, 2020

Expiration: October 14, 2021

Share

Faculty

Sandip P. Patel

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California